Pyrazinamide-induced Hyperuricemia in Pulmonary Tuberculosis Patients
Background: Pyrazinamide is one of the antitubercular drugs used for 2 months in the intensive phase. One of the adverse effects of pyrazinamide is hyperuricemia, with a symptom of arthralgia. This study aims to analyze the incidence of hyperuricemia and arthralgia and their causality in pulmonary t...
Uloženo v:
| Hlavní autoři: | , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Wolters Kluwer Medknow Publications
2024-09-01
|
| Edice: | International Journal of Mycobacteriology |
| Témata: | |
| On-line přístup: | https://journals.lww.com/10.4103/ijmy.ijmy_178_23 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|